Snail transcription factor negatively regulates maspin tumor suppressor in human prostate cancer cells

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Neal, Corey L ^a   Henderson, Veronica ^a   Smith, Bethany N ^a   McKeithen, Danielle ^a   Graham, Tisheeka ^b   Vo, Baohan T ^a   Odero Marah, Valerie A ^a  

^a CLARK ATLANTA UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Maspin; Prostate cancer; Snail

Indexed keywords

LUCIFERASE; MASPIN; TRANSCRIPTION FACTOR SNAIL;

ARTICLE; ASSAY; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL STRAIN LNCAP; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG TARGETING; ENZYME ASSAY; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ONCOLOGICAL PARAMETERS; PROMOTER REGION; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR MOTILITY; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING;

CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL CELLS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MALE; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; SERPINS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEINS;

EID: 84864452523     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-336     Document Type: Article

References (36)

1. Boyer B, Valles AM, Edme N. Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 2000, 60(8):1091-1099. 10.1016/S0006-2952(00)00427-5, 11007946.
2. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000, 2(2):76-83. 10.1038/35000025, 10655586.
3. Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 1995, 154(1):8-20.
4. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2(6):442-454. 10.1038/nrc822, 12189386.
5. Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ, Notorfrancesco KL, Cardiff RD, Chodosh LA. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 2005, 8(3):197-209. 10.1016/j.ccr.2005.07.009, 16169465.
6. Heeboll S, Borre M, Ottosen PD, Dyrskjot L, Orntoft TF, Torring N. Snail1 is over-expressed in prostate cancer. Apmis 2009, 117(3):196-204. 10.1111/j.1600-0463.2008.00007.x, 19245592.
7. Beach S, Tang H, Park S, Dhillon AS, Keller ET, Kolch W, Yeung KC. Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. Oncogene 2008, 27(15):2243-2248. 10.1038/sj.onc.1210860, 2933472, 17952120.
8. Zhu ML, Kyprianou N. Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells. Faseb J 2010, 24(3):769-777. 10.1096/fj.09-136994, 2830130, 19901020.
9. McKeithen D, Graham T, Chung LW, Odero-Marah V. Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells. Prostate 2010, 70(9):982-992. 2877267, 20166136.
10. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994, 263(5146):526-529. 10.1126/science.8290962, 8290962.
11. Zou Z, Zhang W, Young D, Gleave MG, Rennie P, Connell T, Connelly R, Moul J, Srivastava S, Sesterhenn I. Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation. Clin Cancer Res 2002, 8(5):1172-1177.
12. McGowen R, Biliran H, Sager R, Sheng S. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin. Cancer Res 2000, 60(17):4771-4778.
13. Amir S, Margaryan NV, Odero-Marah V, Khalkhali-Ellis Z, Hendrix MJ. Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells. Cancer Biol Ther 2005, 4(4):400-406. 10.4161/cbt.4.4.1617, 3175738, 15846059.
14. Odero-Marah VA, Khalkhali-Ellis Z, Chunthapong J, Amir S, Seftor RE, Seftor EA, Hendrix MJ. Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells. Cancer Biol Ther 2003, 2(4):398-403.
15. Domann FE, Rice JC, Hendrix MJ, Futscher BW. Epigenetic silencing of maspin gene expression in human breast cancers. Int J Cancer 2000, 85(6):805-810. 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5, 10709100.
16. Khalkhali-Ellis Z. Maspin: the new frontier. Clin Cancer Res 2006, 12(24):7279-7283. 10.1158/1078-0432.CCR-06-1589, 3175762, 17189399.
17. Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E, Srivastava S. p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 2000, 275(9):6051-6054. 10.1074/jbc.275.9.6051, 10692390.
18. Zhang M, Magit D, Sager R. Expression of maspin in prostate cells is regulated by a positive ets element and a negative hormonal responsive element site recognized by androgen receptor. Proc Natl Acad Sci U S A 1997, 94(11):5673-5678. 10.1073/pnas.94.11.5673, 20837, 9159131.
19. Odero-Marah VA, Wang R, Chu G, Zayzafoon M, Xu J, Shi C, Marshall FF, Zhau HE, Chung LW. Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells. Cell Res 2008, 18(8):858-870. 10.1038/cr.2008.84, 18645583.
20. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC, Chung LW. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 1994, 54(10):2577-2581.
21. Neal CL, McKeithen D, Odero-Marah VA. Snail negatively regulates cell adhesion to extracellular matrix and integrin expression via the MAPK pathway in prostate cancer cells. Cell Adh Migr 2011, 5(3):247-257.
22. Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004, 6(10):931-940. 10.1038/ncb1173, 15448698.
23. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, De Garcia Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000, 2(2):84-89. 10.1038/35000034, 10655587.
24. Ikenouchi J, Matsuda M, Furuse M, Tsukita S. Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci 2003, 116(Pt 10):1959-1967.
25. Futscher BW, O'Meara MM, Kim CJ, Rennels MA, Lu D, Gruman LM, Seftor RE, Hendrix MJ, Domann FE. Aberrant methylation of the maspin promoter is an early event in human breast cancer. Neoplasia 2004, 6(4):380-389. 10.1593/neo.04115, 1502109, 15256060.
26. Ito R, Nakayama H, Yoshida K, Oda N, Yasui W. Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality. Oncol Rep 2004, 12(5):985-990.
27. Santer FR, Malinowska K, Culig Z, Cavarretta IT. Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion, and maspin expression in human prostate cancer cells. Endocr Relat Cancer 2010, 17(1):241-253. 10.1677/ERC-09-0200, 2829126, 19966016.
28. Primeau M, Gagnon J, Momparler RL. Synergistic antineoplastic action of DNA methylation inhibitor 5-AZA-2′-deoxycytidine and histone deacetylase inhibitor depsipeptide on human breast carcinoma cells. Int J Cancer 2003, 103(2):177-184. 10.1002/ijc.10789, 12455031.
29. Wozniak RJ, Klimecki WT, Lau SS, Feinstein Y, Futscher BW. 5-Aza-2′-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation. Oncogene 2007, 26(1):77-90. 10.1038/sj.onc.1209763, 16799634.
30. Beltran AS, Sun X, Lizardi PM, Blancafort P. Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor. Mol Cancer Ther 2008, 7(5):1080-1090. 10.1158/1535-7163.MCT-07-0526, 18483297.
31. Ayyanathan K, Peng H, Hou Z, Fredericks WJ, Goyal RK, Langer EM, Longmore GD, Rauscher FJ. The Ajuba LIM domain protein is a corepressor for SNAG domain mediated repression and participates in nucleocytoplasmic Shuttling. Cancer Res 2007, 67(19):9097-9106. 10.1158/0008-5472.CAN-07-2987, 17909014.
32. Hou Z, Peng H, Ayyanathan K, Yan KP, Langer EM, Longmore GD, Rauscher FJ. The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression. Mol Cell Biol 2008, 28(10):3198-3207. 10.1128/MCB.01435-07, 2423142, 18347060.
33. Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, Gonias SL, Cheresh DA, Karin M. Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 2007, 446(7136):690-694. 10.1038/nature05656, 17377533.
34. Oshiro MM, Watts GS, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE, Futscher BW. Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. Oncogene 2003, 22(23):3624-3634. 10.1038/sj.onc.1206545, 12789271.
35. Maekawa T, Sano Y, Shinagawa T, Rahman Z, Sakuma T, Nomura S, Licht JD, Ishii S. ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors. Oncogene 2008, 27(8):1045-1054. 10.1038/sj.onc.1210727, 17700520.
36. Lee SH, Lee SJ, Jung YS, Xu Y, Kang HS, Ha NC, Park BJ. Blocking of p53-Snail binding, promoted by oncogenic K-Ras, recovers p53 expression and function. Neoplasia 2009, 11(1):22-31. 26p following 31, 2606115, 19107228.